Plaque modification devices market seen reaching $2.23B by 2030

The plaque modification devices market is projected to rise from $1.62 billion in 2026 to $2.23 billion by 2030, driven by minimally invasive cardiovascular care, AI-guided imaging and broader use of complex vascular interventions. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Plaque modification devices are used in minimally invasive procedures that restore blood flow by removing or altering arterial plaque. - The market’s growth signals rising demand for less invasive cardiovascular and peripheral artery disease treatments. - Faster adoption could expand treatment options for patients with complex vascular conditions and support shorter recovery times.

What happened: - The plaque modification devices market was valued at $1.49 billion in 2025 and is projected to reach $1.62 billion in 2026. - The market is forecast to grow to $2.23 billion by 2030, implying an 8.4% CAGR. - The Business Research Company released a 2026 market outlook covering size, growth drivers, regions and trends. - The report includes a free sample and a full market report with additional analysis. - The report also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

The details: - Rising atherosclerosis, more angioplasty procedures, an aging global population, higher peripheral artery disease cases and advances in interventional cardiology drove recent market growth. - AI-guided vascular imaging, broader use of complex vascular interventions, demand for safer procedures, expansion of outpatient treatment and ongoing device innovation are expected to support future growth. - Expected product trends include minimally invasive plaque extraction methods, precision atherectomy technologies, enhanced embolic protection systems, next-generation catheter-based devices and equipment that reduces procedure times. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The market overview frames plaque modification devices as tools for treating atherosclerotic plaque buildup in blood vessels. - The devices are used in cardiovascular and peripheral artery disease care to reduce complications and improve patient outcomes. - A free sample is available here. - The full report is available here.

Between the lines: - The forecast points to a steady, not explosive, expansion in a market tied closely to procedural innovation. - The emphasis on AI imaging, outpatient care and shorter procedure times suggests buyers are prioritizing efficiency and precision as much as device capability. - The regional split suggests mature demand in North America and stronger growth potential in Asia-Pacific as healthcare access and advanced interventions broaden. - Intuitive Surgical reported placing 415 da Vinci surgical systems in the fourth quarter of 2023, a 12% increase from the prior year, underscoring broader demand for minimally invasive approaches.

What's next: - Market growth is expected to continue through 2030 as device makers push lower-risk, more precise plaque removal tools. - Continued development in vascular imaging, embolic protection and catheter-based systems is likely to shape the next wave of product competition. - Outpatient and complex vascular procedures may become a bigger part of the market mix as providers seek faster, safer interventions.

The bottom line: - Plaque modification devices are moving from a niche cardiovascular toolset toward a broader, technology-driven market with steady global demand.